Aeglea Biotherapeutics shares owned by Hanson McClain Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Hanson McClain Advisors
from 13F filings
Historical chart of Hanson McClain Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by Hanson McClain Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $197 | 9 | 21.89 |
2024-09-30 | $206 | 7 | 29.43 |